Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis.
Saved in:
| Title: | Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis. |
|---|---|
| Authors: | De Paz Linares, Guillermo Antonio1 (AUTHOR) gdepazli@uwo.ca, Opperman, Reid Morgan2 (AUTHOR) oppermrm72@brandonu.ca, Majumder, Mousumi2 (AUTHOR) majumderm@brandonu.ca, Lala, Peeyush K.1 (AUTHOR) pklala@uwo.ca, Hodivala-Dilke, Kairbaan (AUTHOR), Munoz-Felix, Jose M. (AUTHOR) |
| Source: | Cancers. Mar2021, Vol. 13 Issue 5, p942-942. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
